81861-30-5

Usage

Uses

Used in Pharmaceutical Development:
6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine is used as a key intermediate in the synthesis of various pharmaceutical drugs for its potential applications in treating different medical conditions. Its unique chemical structure allows for the development of new drug candidates with specific therapeutic properties.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine serves as a valuable tool for drug discovery and development. Its chemical properties enable researchers to explore its interactions with biological targets, potentially leading to the creation of novel therapeutic agents.
Used in Drug Synthesis:
6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine is utilized as a building block in the synthesis of complex organic molecules, including those with potential pharmaceutical applications. Its versatile structure allows for further functionalization and modification to create a wide range of drug-like compounds.
Used in Drug Design:
In the process of drug design, 6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine is employed as a structural element to create new molecules with desired pharmacological properties. Its presence in a compound can influence the molecule's affinity for specific biological targets, making it an important component in the design of effective drugs.
Used in Drug Screening:
6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine is also used in high-throughput screening assays to identify potential drug candidates. Its chemical properties can be assessed for their ability to modulate biological pathways or interact with specific proteins, contributing to the discovery of new therapeutic agents.

Upstream product

• 52178-91-3 7-methoxy-1,2-dihydronaphthalene 
• 81861-29-2 6-Methoxy-3,4-dihydro-1H-naphthalen-2-one O-methyl-oxime 
• 1447-87-6 2-hydroxy-6-methoxy-1,2,3,4-tetrahydronaphthalene 
• 2472-22-2 6-methoxy-2-tetralone 
• 5486-55-5 2,6-dimethoxylnaphthalene 
• 581-43-1 2.6-dihydroxynaphthalene 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 
• 744174-28-5 N-benzyl-6-methoxytetralin-2-amine 
• 37563-97-6 6-methoxy-3,4-dihydro-[1,2]-naphthoquinone-2-oxime 
• 623-26-7 terephthalonitrile 

Downstream Products

• 81861-31-6 [2-(4-Methoxy-phenyl)-1-methyl-ethyl]-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-amine; hydrochloride 
• 685832-24-0 2-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-isoindole-1,3-dione 
• 4003-88-7 2-amino-6-methoxy-1,2,3,4-tetrahydronaphthalene hydrochloride 
• 81861-33-8 [2-(3,4-Dimethoxy-phenyl)-1-methyl-ethyl]-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-amine; hydrochloride 
• 70312-01-5 2-amino-1,2,3,4-tetrahydro-6-hydroxynaphthalene 

Relevant academic research and scientific papers

INDOLE AHR INHIBITORS AND USES THEREOF

The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.

Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds

We synthesized a series of new naphthalene derivatives: naproxen- and 6-methoxy naphthalene acetic acid-like 1-5. In these compounds the carboxylic function, typical of the classical NSAIDs, was replaced by a methylsulfonamido (1, 2 and 6a-c) or methylsulfonyl (3-5) group present in some selective COX-2 inhibitors. We also synthesized compounds 7 and 8 in which the naphthalene portion was substituted by tetrahydronaphthalene ring. Some of the new compounds were assayed for their enzymatic inhibitory activity towards cycloxygenase enzymes. Compounds 4 and 6b, at a concentration of 10 μM exhibit percentage inhibition values of 65%, 50% and 29%, 87% towards COX-2 and COX-1, respectively. The substitution of carboxylic group with a mehylsulfonamido or a methylsulfonyl groups does not allow to direct the selectivity versus to cycloxygenase enzymes.

Artificial multi-enzyme networks for the asymmetric amination of sec-alcohols

Various artificial network designs that involve biocatalysts were tested for the asymmetric amination of sec-alcohols to the corresponding α-chiral primary amines. The artificial systems tested involved three to five redox enzymes and were exemplary of a range of different sec-alcohol substrates. Alcohols were oxidised to the corresponding ketone by an alcohol dehydrogenase. The ketones were subsequently aminated by employing a ω-transaminase. Of special interest were redox-neutral designs in which the hydride abstracted in the oxidation step was reused in the amination step of the cascade. Under optimised conditions up to 91 % conversion of an alcohol to the amine was achieved. Trickle-down effect: The asymmetric amination of sec-alcohols to the corresponding α-chiral primary amines was performed with a biocatalytic cascade whereby the various steps were interconnected through the cofactors/cosubstrates. In a redox-neutral cascade and under optimised conditions, up to 91 % conversion of an alcohol to the amine was achieved. Copyright

Synthesis and antifungal activities of novel 2-aminotetralin derivatives

Novel 2-aminotetralin derivatives were synthesized as antifungal agents. The 2-aminotetralin scaffold was chemically designed to mimic the tetrahydroisoquinoline ring of the lead molecule described before. Their antifungal activities were evaluated in vitro by measuring the minimal inhibitory concentrations (MICs). Compounds 10a, 12a, 12c, 13b, and 13d are more potent than fluconazole against seven testing human fungal pathogens. Compound 10b exhibits much higher antifungal activities against all of the four fluconazole-resistant clinic Candida albicans strains than the control drugs including amphotericin B, terbinafine, ketoconazole, and itraconazole. The mode of action of some compounds to the potential receptor lanosterol 14α-demethylase (CYP51) was investigated by molecular docking. The studies presented here provide a new structural type for the development of novel antifungal compounds. Furthermore, 10b was evaluated in vivo by a rat vaginal candidiasis model, and it was found that 10b significantly decreases the number of fungal colony counts.

SUBSTITUTED TETRALINS AND INDANES AND THEIR USE

This invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

SUBSTITUTED TETRALINS AND INDANES

The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, dyslipidemia.

DPP IV inhibitors

The present invention relates to compounds of formula (I) wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

Substituted pyridines/pyrimidines, their preparation and their use as pesticides

The present invention relates to novel substituted pyridines/pyrimidines of the formula I where A is CH or N; X is NH, O or S(O)qwhere q is 0, 1 or 2; Y1, Y2and Y3independently of one another are a group of the

Bicyclic fibrinogen antagonists

PCT No. PCT/US95/15937 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Dec. 7, 1995 PCT Pub. No. WO96/18602 PCT Pub. Date Jun. 20, 1996This invention relates to compounds of the formula: which are effective for inhibiting platelet agg

Photoinduced nucleophilic addition of ammonia and alkylamines to methoxy-substituted styrene derivatives

The photoamination of trans-1-arylpropenes (aryl = 2-methoxyphenyl), (1), 3-methoxyphenyl (2) 3,4-dimethoxyphenyl (3), and 4-methoxyphenyl (4) with NH3, i-PrNH2, and t-BuNH2 (RNH2), in the presence of p-dicyanobenzene (p-DCB) gave 2-alkylamino-1 arylpropanes (9) and/or 2-alkylamino-1-aryl-1-(4-cyanophenyl)propanes (10). The photoaminations of 1,2-dihydro-7-methoxynaphthalenes (6-8) with RNH2 in the presence of p-DCB gave mainly 2-alkylamino-1-(4-cyanophenyl)-6-methoxy-1,2,3,4-tetrahydronaphthalene s (13). The photoamination of trans-1-(3,5-dimethoxyphenyl)propene (5) with i-PrNH2 occurred at aromatic ring to give trans-1-(2-isopropylamino-3,5-dimethoxyphenyl)propene (11). The photoaminations of 1-4 and 6-8 with NH3 in the presence of m-dicyanobenzene gave the aminated products without incorporation of cyanophenyl group. Furthermore, the addition of 1,3,5-triphenylbenzene and m-terphenyl for these reactions improved the yields of the photoaminated products.